These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22034395)

  • 1. Brain aging research at the close of the 20th century: from bench to bedside.
    Cidis Meltzer C; Francis PT
    Dialogues Clin Neurosci; 2001 Sep; 3(3):167-80. PubMed ID: 22034395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.
    Meltzer CC; Smith G; DeKosky ST; Pollock BG; Mathis CA; Moore RY; Kupfer DJ; Reynolds CF
    Neuropsychopharmacology; 1998 Jun; 18(6):407-30. PubMed ID: 9571651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional brain imaging: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(22):1-79. PubMed ID: 23074493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating Aging Cognitive Decline Spectrum Using PET and Magnetic Resonance Image Features.
    Dartora CM; de Moura LV; Koole M; Marques da Silva AM;
    J Alzheimers Dis; 2022; 89(3):977-991. PubMed ID: 35988218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropharmacology and receptor studies in the elderly].
    Meltzer CC
    Rev Neurol; 2002 Oct 16-31; 35(8):767-77. PubMed ID: 12402232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
    Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Khan AF; Adewale Q; Baumeister TR; Carbonell F; Zilles K; Palomero-Gallagher N; Iturria-Medina Y;
    Brain; 2022 Jun; 145(5):1785-1804. PubMed ID: 34605898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Rodent Brain Receptor Imaging.
    Herfert K; Mannheim JG; Kuebler L; Marciano S; Amend M; Parl C; Napieczynska H; Maier FM; Vega SC; Pichler BJ
    Mol Imaging Biol; 2020 Apr; 22(2):223-244. PubMed ID: 31168682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical changes in the aging human brain: implications for behavioral impairment and neurodegenerative disease.
    Strong R
    Geriatrics; 1998 Sep; 53 Suppl 1():S9-12. PubMed ID: 9745628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
    Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer's disease: Challenges and opportunities.
    Engels-Domínguez N; Koops EA; Prokopiou PC; Van Egroo M; Schneider C; Riphagen JM; Singhal T; Jacobs HIL
    Neurosci Biobehav Rev; 2023 Jan; 144():104998. PubMed ID: 36526031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype.
    Hof PR; Giannakopoulos P; Vickers JC; Bouras C; Morrison JH
    Rev Neurosci; 1995; 6(2):97-124. PubMed ID: 8564027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking brain imaging and genomics in the study of Alzheimer's disease and aging.
    Reiman EM
    Ann N Y Acad Sci; 2007 Feb; 1097():94-113. PubMed ID: 17413015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the aging brain: study design and baseline findings of the SENIOR cohort.
    Haeger A; Mangin JF; Vignaud A; Poupon C; Grigis A; Boumezbeur F; Frouin V; Deverre JR; Sarazin M; Hertz-Pannier L; Bottlaender M;
    Alzheimers Res Ther; 2020 Jun; 12(1):77. PubMed ID: 32591008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imaging of mild cognitive impairment].
    Meltzer CC; Bell-Mc-Ginty S; Scanlon JM
    Rev Neurol; 2003 Jul 16-31; 37(2):145-9. PubMed ID: 12938074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.
    Rabinovici GD; Karlawish J; Knopman D; Snyder HM; Sperling R; Carrillo MC
    Alzheimers Dement; 2016 Apr; 12(4):510-5. PubMed ID: 27103054
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.